Pathophysiology of neonatal brain lesions: Lessons from animal models of excitotoxicity

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 2, 2005, Pages 185-190

  Mesples B ^a   Plaisant, F ^a   Fontaine, R H ^a   Gressens, P ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cerebral palsy; Glutamate; Inflammation; Interleukin; Microglia

Indexed keywords

CHEMOKINE; CYTOKINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; BRAIN CELL; BRAIN INJURY; CELL INTERACTION; CELL POPULATION; CEREBRAL PALSY; EXCITOTOXICITY; HUMAN; INFLAMMATION; MACROPHAGE; MAST CELL; MICROGLIA; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANIMALS, NEWBORN; CEREBRAL PALSY; CYTOKINES; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HUMANS; INFANT, NEWBORN; INFLAMMATION; INTERLEUKIN-9; LEUKOMALACIA, PERIVENTRICULAR; MICE; MICROGLIA; MODELS, NEUROLOGICAL;

EID: 14844320609     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410022378     Document Type: Review

References (33)

1. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1996;315:81-6.
2. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8.
3. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P. Pro-inflammatory cytokines and IL-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000;47:54-63.
4. Dammann O, Kuban KC, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 2002;8:46-50.
5. McDonald JW, Silverstein FS, Johnston MV. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 1998;459:200-3.
6. Innocenti GM, Berbel P. Analysis of an experimental cortical network: I). Architectonics of visual areas 17 and 18 after neonatal injections of ibotenic acid; similarities with human microgyria. J Neural Transplant Plast 1991;2:1-28.
7. Barks JD, Silverstein FS. Excitatory amino acids contribute to the pathogenesis of perinatal hypoxic-ischemic brain injury. Brain Pathol 1992;2:235-43.
8. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic like lesions. J Neuropathol Exp Neurol 1995;54:358-70.
9. Marret S, Gressens P, Evrard P. Neuronal migration disorders induced by ibotenate in the neocortex. Proc Natl Acad Sci USA 1996;17:543-51.
10. Acarain L, Gonzales B, Castro AJ, Castellano B. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: microglial/macrophage response and major histocompatibility complex class I and II expression. Neuroscience 1999;89:549-65.
11. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-41.
12. Tahraoui SL, Marret S, Bodénant C, Leroux P, Dommergues MA, Evrard P, Gressens P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001;11:56-71.
13. Dommergues MA, Plaisant F, Verney C, Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: a target for neuroprotection. Neuroscience 2003;121:619-28.
14. Husson I, Mesplès B, Bac P, Vamecq J, Evrard P, Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002;51:82-92.
15. Gressens P, Marret S, Hill JM, Brenneman DE, Gozes I, Fridkin I, Evrard P. Vasoactive intestinal peptide prevents excitotoxic hypoxic-like cell death in the murine developing brain. J Clin Invest 1997;100:390-7.
16. Laudenbach V, Calo G, Guerrini R, Lamboley G, Benoist JF, Evrard P, Gressens P. Nociceptin/orphanin FQ exacerbates excitotoxic white matter lesions in the murine neonatal brain. J Clin Invest 2001;107:457-66.
17. Laudenbach V, Medja F, Zoli M, Rossi FM, Evrard P, Changeux JP, Gressens P. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. FASEB J 2002; 16:423-5.
18. Szaflarski J, Ivacko J, Liu XH, Warren JS, Silverstein FS. Excitotoxic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. Mol Brain Res 1998; 55:306-14.
19. Galasso JM, Harrison JK, Silverstein FS. Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am J Pathol 1998;153:1631-40.
20. Galasso JM, Liu Y, Szaflarski J, Warren JS, Silverstein FS. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in the neonatal rat brain. Neuroscience 2000;101:737-44.
21. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553-62.
22. Xu H, Barks JD, Liu YQ, Silverstein FS. AMPA-induced suppression of oligodendroglial gene expression in neonatal rat brain. Dev Brain Res 2001;132:175-8.
23. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-75.
24. Hagan P, Poole S, Bristow AF, Tilders F, Silverstein FS. Intracerebral NMDA injection stimulates production of interleukin-1 beta in perinatal rat brain. J Neurochem 1996; 67:2215-8.
25. Olsson A, Kayhan G, Lagercrantz H, Herlenius E. IL-1 beta depresses respiration and anoxic survival via a prostaglandin-dependent pathway in neonatal rats. Pediatr Res 2003; 54:326-31.
26. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bemardi MA, Brooker G, Mocchetti I. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 2001;21:3104-12.
27. Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 2001;13:493-502.
28. Mesplès B, Plaisant F, Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions. Dev Brain Res 2002; 141:25-32.
29. Skaper SD, Facci L, Kee WJ, Strijbos PJ. Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J Neurochem 2001;76:47-55.
30. Daeffler L, Nadra K, Eichwald V, Ohresser S, Landry Y. Effect of NMDA receptor ligands on mast cell histamine release, a reappraisal. Naunyn Schmiedebergs Arch Pharmacol 1999;359:512-8.
31. Purcell WM, Doyle KM, Westgate C, Atterwill CK. Characterisation of a functional polyamine site on rat mast cells: association with a NMDA receptor macrocomplex. J Neuroimmunol 1996;65:49-53.
32. Patkai J, Mesplès B, Dommergues MA, Fromont G, Thornton EM, Renauld JC, Evrard P, Gressens P. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs. Pediatr Res 2001;50:222-30.
33. Hagberg H, Peebles D, Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002;8:30-8.